Latest Breaking News On - Biosimilars committee - Page 1 : comparemela.com

Under the revised 2022 WHO Biosimilars Guideline, IGBA says regulatory authorities can confidently revaluate biosimilar access requirements.

Vivian frittelliJulie marBiosimilars committeeWorld health organizationInternational genericBiosimilar medicines associationEmbracing scienceBiosimilars guidelineAccess policy blueprintRegulatory efficiency